Nuvalent, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$75.01 | $2.72 B | -49.3 | 163 | $107.94 M |
ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
KNSA
Kiniksa Pharmaceuticals, Ltd. |
$20.02 | $1.35 B | 146.62 | 315 | $423.24 M |
PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
TVTX
Travere Therapeutics, Inc. |
$18.71 | $542.80 M | -1.32 | 385 | $233.18 M |
UTHR
United Therapeutics Corporation |
$355.39 | $12.20 B | 13.02 | 1305 | $2.88 B |
VRDN
Viridian Therapeutics, Inc. |
$20.07 | $776.72 M | -2.71 | 143 | $302,000 |
VTYX
Ventyx Biosciences, Inc. |
$2.42 | $229.83 M | -1.01 | 79 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
